10 min read

Positioning and Outlook - 2026-08-22

General & impersonal research commentary. Not investment advice.

Published 2026-08-22

A technology-led rally powered by strong artificial-intelligence earnings and expectations that the Federal Reserve will hold rates steady sits on top of strained corporate credit, with survival scores weak, dozens of issuers in danger territory, and a heavy buyback bid providing the main support beneath the surface.

Recent Events

Equities pushed higher through the middle of the period as strong AI-driven earnings lifted the technology sector and a benign inflation reading reinforced bets that the Federal Reserve would keep rates on hold, with the Fed's own communications striking a moderate tone and Cook delivering remarks on the outlook for the U.S. and Alaskan economies. The credit tape told a more strained story beneath the rally: corporate credit survival scores sat in the low-to-mid twenties out of 100 with roughly 50 issuers in danger territory, high-yield spreads went sideways on the week, and the main counterweight remained a heavy buyback bid, more than 12,000 active programs representing some $4.5 trillion in trailing-twelve-month repurchases. Single names added texture, with On Holding tempering its sales outlook after missing quarterly revenue targets, the FDA issuing Class I device recalls for Boston Scientific's neuromodulation unit and AVID Medical, and Veralto reporting results.

Macro & policy
2026-08-12Wall St gains as AI earnings lift tech, inflation data supports rate-hold bets
2026-08-11On Holding Tempers Sales Outlook After Missing Quarterly Revenue Targets
2026-08-04Only the Bank of Japan Can Arrest the Yen’s Decline
2026-08-20Fed Communication: 15/100 (MODERATE)
Credit & corporate
2026-08-20Credit survival: avg 25/100, 48 in danger
2026-08-20Buybacks: 12231 active, $4465B TTM
2026-08-20HY OAS Weekly: FLAT → hold cash
2026-08-13Credit survival: avg 22/100, 51 in danger
On the calendar
2026-08-05Cook, Outlook for the U.S.
Notable news
2026-08-12BSX (Boston Scientific Neuromodulation Corporation)
2026-08-12AVID Medical, Inc.
2026-08-05Veralto Reports First Quarter 2024 Results
2026-08-058-K Results of Operations (Earnings)

Upcoming Events

The heavy end of the forward calendar is a tightly packed run of central-bank decisions in mid-September: the ECB's Governing Council meets on September 10, the FOMC decides on September 16, the Bank of England follows a day later, and the Bank of Japan closes the week on September 18, with the PBOC's loan prime rate fixing landing on September 21. Four major policy boards moving within little more than a week compresses the window in which rate expectations can reprice, leaving the market trading from decision to decision rather than off secondary data in between. The nearer stretch around August 21 carries a different kind of weight, a monthly options expiration that tends to swell volumes and positioning flows, an FDA decision date for Deramiocel on August 22, and a cluster of single-name trial readouts including CagriSema, Pembrolizumab and Danicopan. Beneath it all sits a broad earnings undercurrent, with 191 reports scheduled and PVH among the first out of the gate, keeping stock-level dispersion alive while the macro calendar builds toward its September peak.

2026-08-21 Monthly options expiration (OpEx) (US)
2026-08-21 phase2 readout: CagriSema (Cagrilintide B and Semaglutide I) (NVO) (US)
2026-08-21 phase2 readout: Pembrolizumab (MRK) (US)
2026-08-22 PDUFA: Deramiocel (CAPR) (US)
2026-08-23 phase2 readout: PF-07220060 + PF-07104091 combination dose escalation (PFE) (US)
2026-08-24 phase3 readout: Danicopan (AZN) (US)
2026-08-24 13-Week BILL auction (US)
2026-09-10 ECB Governing Council monetary policy meeting (EZ)
2026-09-16 FOMC monetary policy decision (US)
2026-09-17 Bank of England MPC monetary policy decision (UK)
2026-09-18 Bank of Japan Monetary Policy Meeting (JP)
2026-09-21 PBOC Loan Prime Rate (LPR) fixing (CN)
Plus 191 corporate earnings reports scheduled in the window.

Macro Projections

The next five weeks pack in nearly every catalyst that matters, PCE and GDP on 8/26, payrolls on 9/4 (prediction markets give only about 25% odds of a print above 80,000 jobs), the ECB on 9/10 and CPI on 9/11, then the central-bank stack of FOMC 9/16, BoE 9/17 and BoJ 9/18, with the BoJ carrying outsized weight because the carry model still tags dollar-yen near 160 and Japanese government bond yields have breached 2.85%. CPI is the fulcrum of the near-term leg: the crowd prices August inflation above 3.2% year over year at 87%, and the 10-year breakeven, the market's implied inflation rate, is accelerating higher at 2.34%, a 71st-percentile reading, so confirmation keeps the Fed on hold into year-end (the fed-reaction model puts hold propensity at 84.6% against 15.9% for intervention), while a soft miss would squeeze a front end where leveraged funds are short the two-year at a 52-week extreme of +3.43, a stretch that would unwind violently on a dovish surprise. Away from rates, the regime reads calm on every top-tier gauge: high-yield spreads (the extra yield junk bonds pay over Treasuries) have sat in a 2.67–2.78% band for two weeks, bond-market volatility via the MOVE index is stable at 73.4 bp, the VIX is 16.0, currency volatility runs below average, and all ten correlation pairs sit in calm with no break flags, and even the carry model's disorderly-unwind probability, still the largest single branch, is falling at 0.438 from 0.503. Rates are the exception to that calm: the 10-year at 4.738% is accelerating upward and the 30-year at 5.276% sits in the 94.6th percentile of its history, last higher on 8/18, an extreme the two-year (4.19%, 56th percentile, stable) pointedly does not share. That long-end stress is partly a policy fight, Treasury buybacks and the reported Bessent yield-suppression push are holding yields down at the dollar's expense, while WSJ reporting of undisclosed Warsh–Trump contacts adds a Fed-independence risk premium the rates market looks only about half to be pricing. The cyclical months-to-quarters view forks from here: the outlook assigns roughly 25% to the calm-credit regime breaking by Q4, most likely via an exogenous trigger, with the tells being high-yield spreads sustained above 3.25% and MOVE above 100 (historically, such volatility spikes force deleveraging with a 0.74 hit rate across 54 episodes). The cleanest live branch is oil: if the Hormuz near-closure, three days old, escalates to actual transit disruption by mid-September, crude re-prices violently given an 0.86 historical hit rate for supply shocks feeding through to CPI, whereas if it fades, the +4.4 million-barrel build and the crowd's roughly $79 WTI pricing hold; as it stands the market prices near-zero supply premium against a documented closure edge, with the geopolitical-risk gauge at 144.5, down from 225 but still elevated. On the structural multi-year leg the reasoning shifts from catalysts to valuation and carries the lowest confidence by construction: long-dated Treasuries read as a value trap despite the 30-year's extremity because the trajectory remains adverse, while earnings yields of 5.98% in emerging markets and 5.38% in developed ex-US hold a 140–200 bp advantage over the US at 3.98% (a cyclically adjusted multiple of 41.8), and sentiment at a composite 70 in greed territory confirms rather than drives the read, with the whole chain explicitly falsifiable via spreads above 3.25% for two consecutive weekly reads, MOVE above 100, or WTI above $95 breaking the calm-higher-for-longer frame, and a 30-year back below 4.90% with breakevens rolling over breaking the rates leg.

Near term  expires Sep 21, 2026
The Fed holds the policy rate unchanged (3.50%–3.75% band) at the September 16 FOMC, no cut, no hike.
Cross-validated across the fed-reaction model (hold propensity 84.6%, intervention 15.9%, both stable) and crowd pricing (Kalshi: cut before 2027 at only 12.4%; fed funds upper bound >3.75% post-meeting at ~58%, implying no change from the current band). CPI >3.2% priced at 87% argues against a cut; payrolls >80k at 25% argues against a hike.
Near term  expires Sep 21, 2026
WTI crude stays below $90/bbl over the next 30 days despite the active Iran/Hormuz near closure situation.
Tier-1 physical data (commercial crude +4.4mmbl weekly build to 428.8mmbl) and crowd pricing (Kalshi WTI ~$79, 96–98% above $79 handles; Brent >$92.50 only ~50%) both say the market sees no supply loss, and GPR is falling (144.5 from a 225.2 peak). Confidence is deliberately low: the geopolitical_energy_closure edge is freshly firing (provenance rank 4) and this is precisely the unpriced tail, the claim bets the tai…
Cyclical  expires Nov 20, 2026
The 30Y Treasury yield remains at or above 5.0% at the 90-day horizon, the long-end extreme persists rather than mean-reverts.
The 30Y at 5.276% is at the 94.6th percentile of its history (last higher 2026-08-18) and accelerating_positive; the 10Y (4.738%) is also accelerating_positive and breakevens are rising (2.34%, +0.10 in a week). Kalshi prices CPI >3.2% at 87%, keeping term premium bid.
Cyclical  expires Nov 20, 2026
HY OAS stays below 3.25% through the 90-day horizon, the calm-credit regime muddles through the autumn catalyst stack.
HY OAS has been pinned in a 2.67–2.78% range for two weeks with zero tightening weeks; MOVE is calm and stable at 73.4 bp; all ten correlation pairs show calm regime with no break flags; VIX at 16.0 and VVIX falling. The credit classifier's at 2.00 is stable (not deteriorating) though its trail is noisy, and the carry model's disorderly-unwind probability is falling (0.438, accelerating_negative).
Cyclical  expires Feb 18, 2027
No NBER recession is declared for 2026, and real GDP growth for Q3 2026 comes in above 1.5%.
Cross-validated: Kalshi prices a 2026 recession at just 7% and Q3 GDP >1.5% at 78%; credit (HY OAS 2.75%, false-bottom risk LOW in the monthly classifier), calm financial-stress, and stable correlations all say expansion continues. Unemployment >4.2% priced at only 23%.
Secular  expires Aug 22, 2027
Developed ex-US and emerging-market equities outperform US equities over the next 12 months on a total-return basis.
The valuation gap is the widest anchor in the substrate: US earnings yield 3.98% (CAPE 41.8, implied 10y real return 2.39%) vs developed ex-US 5.38% and EM 5.98%, a 140–200bp yield cushion. The yield-suppression flow is weighing on the dollar (rank-3 variant edges), which historically amplifies ex-US relative returns.

Positioning

With high-yield credit spreads near 2.75% and the backdrop calm, the model portfolio sizes positions in direct proportion to conviction, conviction being the screening kernel's composite score, a modelled blend of expected upside drift against drawdown probability, so the highest-scoring names carry the largest weights. Overall risk appetite is then calibrated by a small set of structural mechanisms, each treated as a weighable input rather than a prediction: merger-arb completion has historically been associated with an upside move in the target's spread 89% of the time across 47 prior firings, while the oil-supply-to-headline-CPI and commodity-production-loss channels show base rates of 86% and 80% on thinner histories of seven and five firings, misses counted in each case. Every mechanism is discounted for what the market already prices, roughly 60% for the first two and 40% for the third, so only the unpriced portion feeds into sizing. The holdings and composite scores that follow show how that arithmetic settles out across the book.

merger arb completion → merger target arb spread · 89% base rate · n=47 · 60% pricedoil supply shock headline cpi → headline CPI · 86% base rate · n=7 · 60% pricedcommodity production loss → agricultural commodity · 80% base rate · n=5 · 40% priced

Model Portfolio

The model portfolio is effectively an all-cash book this week: half sits in a dedicated money-market sleeve and the remainder is unallocated, leaving nothing committed to risk assets. That money-market stake is being treated as dry powder, earmarked for staged deployment into the cascade as the credit and volatility picture resolves, rather than as a permanent home. The latest weekly rotation review produced no changes, so the standing positions carry over untouched from the prior allocation, with the book still waiting on conditions to shift before putting that reserve to work.

Cash 50.0%
NameWeightThesis
Cash · 50.0%
Money Market
50.0%
money-market / cash

Track Record

The record so far is modest and reported without varnish: across roughly 69 days of scored ideas, the model's one-day calls have landed just over half the time with essentially flat average alpha, while results fade at longer horizons, under half of one-week calls beat their benchmark, and only about a third of four-week calls did, with average alpha at that window running around negative 1.6%. Every evaluated idea is counted here, not a flattering subset, and while the sample of several hundred calls per horizon is no longer tiny, it still covers barely two months of market conditions. The three-month horizon has yet to mature, with first readings expected around mid-September. The discipline is the point: each call is written down before the outcome is known and scored when the horizon arrives, whatever the result.

37%
Hit rate
4w, n=747
-1.6%
Mean alpha (4w)
-0.3%
Mean return (4w)

Macro forecasts: 78 graded, 423 open — each call is scored against what actually happened when its horizon arrived.

Positions, conflicts & disclosures

DISCLAIMER — NOT INVESTMENT ADVICE (DECISION-LINKED)

This publication provides GENERAL and IMPERSONAL commentary and analysis on a regular schedule. The same content is provided to every subscriber. It is NOT investment advice, is NOT tailored to any individual, and does NOT account for your personal financial situation, objectives, or risk tolerance.

This post reports (1) a rules-based MODEL portfolio — target weights produced by an automated system's published rules, identical for all readers — and (2) DECISION-LINKED activity: how that affiliated automated system actually implemented, or has queued to implement, those rules in accounts belonging to the publication's operator. Model weights are not an account statement; the decision-linked positions and pending orders are REAL and belong to accounts affiliated with this publication's operator. We publish them for transparency on a fixed schedule under our Trading & Publication Policy [link] — not as a recommendation that any security or strategy is suitable for you. Because the publisher and/or operator hold or intend to establish positions in the securities discussed, a conflict of interest exists and our interests may differ from yours.

Nothing here is a recommendation to buy, sell, or hold any security for you specifically. Investing involves risk, including loss of principal. Past performance — model or actual — does not guarantee future results.

[Publisher LLC] is not a registered investment adviser and does not provide individualized investment advice. Consult a licensed professional before making any investment decision. See full disclosures, methodology, and our Trading & Publication Policy at [link].

POSITIONS DISCLOSURE: this is a hypothetical, rules-based model portfolio, not a statement of any individual's actual account; the publisher and/or author may hold positions in one or more of the securities listed.

CONFLICT OF INTEREST: because the publisher and/or author may hold listed securities, a conflict of interest exists and could benefit from price movements; the publisher receives no compensation for featuring any security, and this impersonal model illustration is not personalized investment advice or a solicitation to transact.

MICRO-CAP CAVEAT: some listed names are micro-capitalization securities held at small model weights; micro-caps carry elevated liquidity and volatility risk and are unsuitable for short-term trading — the small weights reflect that risk, and nothing here is a recommendation to scalp or rapidly trade thinly-traded securities.

Disclaimer — not investment advice

This publication is a bona fide financial publication of general and regular circulation. It provides GENERAL and IMPERSONAL commentary and analysis only. The same content is provided to every reader on a regular schedule. It is NOT investment advice, is NOT tailored to any individual, and does NOT account for your personal financial situation, objectives, or risk tolerance.

Nothing here is a recommendation to buy, sell, or hold any security for you specifically. Any model portfolio described is a rules-based, hypothetical illustration provided to all readers identically — it is not a recommendation personalized to you. Investing involves risk, including loss of principal. Past performance — and any hypothetical or backtested performance — does not guarantee future results.

Clarke Envoy is not a registered investment adviser and does not provide individualized investment advice. Consult a licensed professional before making any investment decision.